CALA News Alert Calithera Biosciences Inc. (CALA) 20.20 01/01/2015

New Post Public Reply Private Reply Replies (0) Message Board

Jan 1, 2015 at 3:57 PM

Calithera Biosciences Inc. (CALA) 20.20 $CALA

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Dec 31, 12:05PM CST

FATE: 5.03 (-0.62), SIBC: 20.72 (+5.36), FUR: 15.59 (-2.32), DRAM: 1.70 (-0.23), NRX: 13.35 (+8.70), MEIL: 1.36 (+0.35), MIG: 8.46 (+1.33), BCLI: 4.76 (+0.88), ABAC: 1.73 (-0.18), GBR: 1.51 (+0.23), NDRM: 14.04 (-4.10), RCMT: 7.00 (-1.55), AGRX: 6.14 (-0.56), REN: 1.32 (+0.28), KEG: 1.67 (-0.19), LIME: 2.93 (+0.52), CALA: 20.20 (+1.89), CJJD: 2.90 (-0.25), CBMG: 12.91 (+1.39), GNI: 13.90 (-1.90)

Calithera (CALA) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 26, 8:51AM CST
Calithera (CALA) Shares March Higher, Can It Continue?
CALA: 20.20 (+1.89)

Profit taking continues for Calithera Bio
Seeking Alpha - at Seeking Alpha - Wed Dec 17, 10:38AM CST

CALA: 20.20 (+1.89)

Calithera Biosciences Slumps: CALA Tanks 10.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 7:50AM CST
Calithera Biosciences (CALA) fell by over 10% in the last trading session amid huge volumes, reversing its recent uptrend, as the stock is now up nearly 185% in the past one month.
LCI: 42.88 (-0.65), SCMP: 14.28 (+0.39), CALA: 20.20 (+1.89), IG: 8.80 (-0.12)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 8:12AM CST

FRO: 2.51 (-0.08), TLM: 7.83 (unch), SPHS: 0.54 (+0.03), HGSH: 4.29 (-0.12), SN: 9.29 (-0.04), NBG: 1.79 (unch), AXAS: 2.94 (unch), RVBD: 20.41 (unch), OPK: 9.99 (+0.14), ANTH: 1.58 (-0.03), ONVO: 7.25 (-0.41), KEG: 1.67 (-0.19), CALA: 20.20 (+1.89), XCO: 2.17 (+0.07), CRUS: 23.57 (+0.02), ARCP: 9.05 (-0.06)

Calithera Biosciences, Inc. (CALA) in Focus: Stock Soars 29.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 8:18AM CST
Calithera Biosciences, Inc. (CALA) was a big mover last session, as the company saw its shares rise by nearly 30% on the day.
LCI: 42.88 (-0.65), SCMP: 14.28 (+0.39), CALA: 20.20 (+1.89), IG: 8.80 (-0.12)

Calithera Presents Novel Pharmacodynamic Assay Data Confirming Glutaminase Inhibition in Tumor Biopsy Samples From Patients Treated With CB-839
GlobeNewswire - Wed Dec 10, 12:00PM CST
Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer agents, today announced results of studies with primary human breast tumors that support glutaminase as a potential target in triple negative breast cancer (TNBC). Using a novel pharmacodynamic assay designed to measure the extent of glutaminase inhibition in a single post-dose tumor biopsy sample, significant glutaminase inhibition was observed following oral administration of CB-839. These data were presented during the San Antonio Breast Cancer Symposium in San Antonio, Texas. Calithera is developing CB-839, a potent, selective and orally bioavailable glutaminase inhibitor that is currently in Phase I clinical trials in solid and hematological malignancies.
CALA: 20.20 (+1.89)

Calithera up again after ASH presentation
Seeking Alpha - at Seeking Alpha - Wed Dec 10, 11:08AM CST

CALA: 20.20 (+1.89)

Calithera Biosciences Gains Exclusive, Worldwide License to Mars Symbioscience's Arginase Inhibitors
GlobeNewswire - Tue Dec 09, 8:12AM CST
Calithera Biosciences, Inc. (Nasdaq:CALA) announced today the signing of an exclusive global license agreement with Mars Symbioscience ("Symbioscience"

, a division of Mars, Incorporated, granting Calithera rights to research, develop and commercialize Symbioscience's portfolio of arginase inhibitors, discovered as part of Mars' cocoa flavanol research program, for use in human healthcare. Symbioscience's preclinical arginase inhibitor program will enhance Calithera's efforts to submit an Investigational New Drug application for an arginase inhibitor with the FDA for the treatment of cancer near the end of 2015.
CALA: 20.20 (+1.89)

Calithera up after ASH presentation
Seeking Alpha - at Seeking Alpha - Mon Dec 08, 2:45PM CST

CALA: 20.20 (+1.89)

Calithera Presents Preclinical Study Findings for CB-839 at the 56th American Society of Hematology Annual Meeting
GlobeNewswire - Mon Dec 08, 11:00AM CST
-Potential Biomarkers of Response to CB-839 Identified in Myeloma Cells
CALA: 20.20 (+1.89)

Calithera Biosciences hires H. Ward Wolff to board
M2 - Wed Dec 03, 7:06AM CST
Pharmaceutical company Calithera Biosciences (NasdaqGS:CALA) reported on Tuesday the addition of H. Ward Wolff to its board of directors as well as chair of its Audit Committee.
PTLA: 28.32 (-0.24), CALA: 20.20 (+1.89), SGMO: 15.21 (+0.39)

Calithera Biosciences Appoints H. Ward Wolff to Board of Directors
GlobeNewswire - Tue Dec 02, 4:00PM CST
Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer, announced today the appointment of H. Ward Wolff to the company's Board of Directors, where he will chair the company's Audit Committee. Mr. Wolff is currently Executive Vice President and Chief Financial Officer of Sangamo BioSciences, Inc.
CALA: 20.20 (+1.89), SGMO: 15.21 (+0.39)

Calithera Biosciences net loss worsens in Q3
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 10:49AM CST

CALA: 20.20 (+1.89)

Calithera Biosciences net loss of $5.24M
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 8:11AM CST

CALA: 20.20 (+1.89)

Calithera Reports Financial Results for the Fiscal Quarter Ended September 30, 2014
GlobeNewswire - Fri Nov 14, 7:30AM CST
Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer, announced today its financial results for the fiscal quarter ended September 30, 2014.
CALA: 20.20 (+1.89)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

VISTAR Oakland Workers Join Teamsters for Unity

Warehouse Workers Break Free from the Shackles Ever had that feeling, where enough is enough? That's where 37 warehouse workers at VISTAR find themselves, shaking off the dust and signing up with Teamsters Local 853. This ain't just a fleeting wind of change; it's the whole damn storm. Turning Points and Union Victories Think about it. This move by the VISTAR warehouse...

Nomada Fund Launches: A Game-Changer in New Media

Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...

Kansai Medical Ushers in New Era of Cancer Research

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Ryan Stills: Vegan Powerlifter Defies Odds, Wins Sixth World Title

Ryan Stills: A Comeback Story for the Ages Ryan Stills isn't just lifting weights; he's lifting the entire perception of what's possible after a heavy surgical setback. We're talking about a guy who stared down a hemi-shoulder replacement—a career ender for many—and came out the other side with a whole new set of gold medals. Two years ago, some might have written him...

Taiwan Excellence Sparks Smart Automotive Innovation at SEMA

Taiwan's making waves, folks, and it's not your everyday splash in the automotive pool. At SEMA 2026, Taiwan Excellence Pavilion is the place to be with its array of intelligent automotive solutions. This ain't just your run-of-the-mill car show gimmickry—it's the future rolling in real-time. Driving Innovation: From Components to Smart Systems The name of the game is...

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

D2L Ventures into Vietnam with Van Lang Alliance

Unlocking New Frontiers in Vietnam's Education Well, looks like D2L is rolling into Vietnam with the kind of gusto you'd expect from a company that fancies itself a trailblazer in learning tech. This ain't just another humdrum expansion story; it's a five-year handshake with Van Lang Education Group that's got the tech firm dropping its anchor in a fresh and promising...

Community Heritage Financial Declares Q3 2026 Dividend

Dividend Declared Amidst Challenging Times There's nothing quite like the ringing of a cash register, and for Community Heritage Financial, Inc. (OTCID: CMHF), that's what an $0.08 per share dividend feels like. Declared for the third quarter of 2026, this payout is set to line the pockets of shareholders who made the cut by October 30, 2026. The folks waiting for their...

Kenneth Smith Takes Helm for Trends Int’l Expansion

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Standex's New Financial Lead: Stoddard Takes Helm

New Financial Captain Aboard Standex's Ship Alright, here's something that'll have investors nodding along with interest: Standex International has just named Samantha L. Stoddard as their incoming Chief Financial Officer and Treasurer, effective December 1, 2026. Now, Standex isn't some scrappy upstart. We're talking about a veteran manufacturer intricately working...